Evidence map›Paper›PMID 24777453›Full record

SynthesisNature genetics2014

Rare and low-frequency coding variants in CXCR2 and other genes are associated with hematological traits.

Paul L Auer, Alexander Teumer, Ursula Schick, Andrew O'Shaughnessy, Ken Sin Lo, Nathalie Chami, Chris Carlson, Simon de Denus, Marie-Pierre Dubé, Jeff Haessler and 16 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 8 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 8 syntheses or guidelines pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Journal of the American Society of Nephrology : JASN · 2017
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Case Report: NovelFrontiers in immunology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 3 countries.

Paul L Auer1] School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA. [2] Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Alexander TeumerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.ORCID 000000028309094X
Ursula SchickPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Andrew O'ShaughnessyDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Ken Sin LoMontreal Heart Institute, Montreal, Quebec, Canada.
Nathalie ChamiMontreal Heart Institute, Montreal, Quebec, Canada.
Chris CarlsonPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Simon de Denus1] Montreal Heart Institute, Montreal, Quebec, Canada. [2] Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada. [3] Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada.
Marie-Pierre Dubé1] Montreal Heart Institute, Montreal, Quebec, Canada. [2] Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada. [3] Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada.
Jeff HaesslerPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Rebecca D JacksonDivision of Endocrinology, Diabetes and Metabolism, Ohio State University, Columbus, Ohio, USA.
Charles KooperbergPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Louis-Philippe Lemieux PerreaultMontreal Heart Institute, Montreal, Quebec, Canada.
Matthias NauckInstitute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
Ulrike Peters1] Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA.
John D Rioux1] Montreal Heart Institute, Montreal, Quebec, Canada. [2] Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada. [3] Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada.
Frank SchmidtInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Valérie TurcotMontreal Heart Institute, Montreal, Quebec, Canada.
Uwe VölkerInterfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
Henry VölzkeInstitute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
Andreas GreinacherInstitute for Immunology and Transfusion Medicine, University Medicine Greifswald, Greifswald, Germany.
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jean-Claude Tardif1] Montreal Heart Institute, Montreal, Quebec, Canada. [2] Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada. [3] Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada.
George A Diaz1] Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [2] Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [3].
Alexander P Reiner1] Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [2] Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington, USA. [3].
Guillaume Lettre1] Montreal Heart Institute, Montreal, Quebec, Canada. [2] Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada. [3] Faculty of Pharmacy, Université de Montréal, Montreal, Québec, Canada. [4].
Montreal Heart Institute · CAFred Hutch Cancer Center · USUniversitätsmedizin Greifswald · DEIcahn School of Medicine at Mount Sinai · USThe Ohio State University · US

Funding

Regulation of IgA class switching in the intestinal mucosaP01AI061093 · NIAID · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CUNNINGHAM-RUNDLES, CHARLOTTE · 2004 to 2021
$29.8M
Molecular pathological epidemiology of colorectal cancerU01CA137088 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2009 to 2018
$21.8M
Northwest Genomics CenterRC2HL102926 · NHLBI · UNIVERSITY OF WASHINGTON · PI GREEN, PHILIP P, NICKERSON, DEBORAH A · 2009 to 2009
$11.0M
Comprehensive Sequencing and Analysis of Variation in NHLBI CohortsRC2HL102925 · NHLBI · BROAD INSTITUTE, INC. · PI ALTSHULER, DAVID, GABRIEL, STACEY · 2009 to 2009
$10.2M
Use of Biomarkers in Diagnosis, Prognosis, Risk Prediction and Early Detection ofP01CA053996 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRENTICE, ROSS L · 1991 to 2015
$9.4M
Cancer Prevention Trng-Nutrition, Exercise &GeneticsR25CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI WHITE, EMILY · 2002 to 2016
$7.3M
GWAS of Hormone Treatment and CVD and Metabolic Outcomes in the WHIU01HG005152 · NHGRI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI REINER, ALEXANDER P · 2009 to 2011
$2.6M
WHI Sequencing Project (WHISP)UC2HL102924 · NHLBI · OHIO STATE UNIVERSITY · PI CARLSON, CHRISTOPHER S, JACKSON, REBECCA D · 2010 to 2010
$2.4M
WHI Sequencing Project (WHISP)RC2HL102924 · NHLBI · OHIO STATE UNIVERSITY · PI CARLSON, CHRISTOPHER S, JACKSON, REBECCA D · 2009 to 2009
$2.1M
Genetic Variants Associated with CVD Risk and Hormone Therapy InteractionsR21HL121422 · NHLBI · UNIVERSITY OF WISCONSIN MILWAUKEE · PI AUER, PAUL L. · 2014 to 2015
$262k
NCI NIH HHS P01 CA053996NCI NIH HHS R25 CA094880NCI NIH HHS U01 CA137088NHGRI NIH HHS U01 HG005152NHLBI NIH HHS HHSN268201100046CNHLBI NIH HHS R21 HL121422NHLBI NIH HHS RC2 HL102924NHLBI NIH HHS RC2 HL102925NHLBI NIH HHS RC2 HL102926NHLBI NIH HHS UC2 HL102924NIAID NIH HHS P01 AI061093WHI NIH HHS HHSN268201100001CWHI NIH HHS HHSN268201100002CWHI NIH HHS HHSN268201100003CWHI NIH HHS HHSN268201100004C
6 · The paper itself

Abstract

Hematological traits are important clinical parameters. To test the effects of rare and low-frequency coding variants on hematological traits, we analyzed hemoglobin concentration, hematocrit levels, white blood cell (WBC) counts and platelet counts in 31,340 individuals genotyped on an exome array. We identified several missense variants in CXCR2 associated with reduced WBC count (gene-based P = 2.6 × 10(-13)). In a separate family-based resequencing study, we identified a CXCR2 frameshift mutation in a pedigree with congenital neutropenia that abolished ligand-induced CXCR2 signal transduction and chemotaxis. We also identified missense or splice-site variants in key hematopoiesis regulators (EPO, TFR2, HBB, TUBB1 and SH2B3) associated with blood cell traits. Finally, we were able to detect associations between a rare somatic JAK2 mutation (encoding p.Val617Phe) and platelet count (P = 3.9 × 10(-22)) as well as hemoglobin concentration (P = 0.002), hematocrit levels (P = 9.5 × 10(-7)) and WBC count (P = 3.1 × 10(-5)). In conclusion, exome arrays complement genome-wide association studies in identifying new variants that contribute to complex human traits.

Indexed as

Leukocyte CountPlatelet CountAdultAgedChemotaxisCongenital Bone Marrow Failure SyndromesExomeFemaleFrameshift MutationGenome-Wide Association StudyGenotypeHematocritHematopoiesisHemoglobinsHumansJanus Kinase 2HemoglobinsJAK2 protein, humanJanus Kinase 2Receptors, Interleukin-8B

Identifiers

PMID24777453
PMCPMC4050975
OpenAlexW2013504017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.